# A Challenging Case: Unraveling the Complexities of Undifferentiated Connective Tissue Disease

## TL;DR

This paper discusses the difficulty in diagnosing undifferentiated connective tissue disease, especially in young patients, and highlights the importance of rechecking ANA levels and considering UCTD in cases with unexplained symptoms.

## Contribution

The paper presents a case emphasizing the need to recheck ANA levels in UCTD patients with initially negative results and persistent symptoms.

## Key findings

- The patient's symptoms resolved after six months with hydroxychloroquine treatment.
- Initial negative ANA tests can become positive over time in UCTD cases.
- Early treatment improves outcomes in patients with UCTD and inconclusive lab results.

## Abstract

Undifferentiated connective tissue disease (UCTD) poses a significant diagnostic challenge due to its wide array of clinical presentations and the absence of specific diagnostic criteria. We present the case of a 22-year-old female who initially exhibited symptoms resembling the common flu, including recurrent fever, headaches, and constitutional symptoms. Despite initial tests showing no abnormalities and negative autoimmune serology, her symptoms persisted, prompting further investigation. Although subsequent imaging studies yielded no definitive diagnosis, her elevated inflammatory markers and progressively positive antinuclear antibody (ANA) test after the initial negative result suggested an underlying autoimmune process.

After six months of persistent symptoms, treatment with hydroxychloroquine initiated by a rheumatologist led to a remarkable resolution of her symptoms. This case highlights the challenge of diagnosing UCTD, particularly in young individuals, where symptoms may manifest early in life without clear laboratory abnormalities, sometimes with initial negative ANA, making it a learning point to recheck ANA levels even if they were initially negative. It underscores the importance of considering UCTD in patients with unexplained symptoms and inconclusive laboratory findings, as early initiation of appropriate treatment can significantly alleviate symptoms and improve patient outcomes.